Ex parte REINHERZ et al. - Page 6




          Appeal No. 94-1483                                                          
          Application No. 07/695,141                                                  


          material coding for soluble, single chain T-cell receptors for              
          a wide variety of different antigens.  With respect to all                  
          antigens except fluorescein, the specification does not set                 
          forth a precise definition of the genetic material involved,                
          e.g., by the description of a representative number of                      
          nucleotide sequences.  Therefore, consistent with the                       
          principles enunciated in Univ. of Cal., 119 F.3d at 1566-69,                
          43 USPQ2d at 1404-07, we find that claims 14 through 16, 18,                
          20 through 22, 24 through 28, and 32 through 34 fall short of               
          complying with the written description requirement of the                   
          statute because appellants' specification does not provide the              
          kind of specificity necessary to support them.                              

          Enablement Requirement, 35 U.S.C. § 112, First Paragraph                    
               Claims 2 through 16, 18, 20 through 22, 24 through 28 and              
          31 through 34 are rejected under 35 U.S.C. § 112, first                     
          paragraph, as based on a non-enabling disclosure.                           
               The claimed invention is directed to a soluble, single                 
          chain polypeptide comprising a Ti $ subunit fragment joined to              
          a Ti " subunit fragment by an amino acid linker (claim 3) and               
          a similar soluble, single chain polypeptide comprising a Ti (               
          subunit fragment joined to a Ti * subunit fragment, also by an              
                                         -6-                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007